Anticoagulant and antithrombotic therapy in the PCI of NSTE-ACS


Jamil Abdalla Saad
2014-04-22

SOLACI’S  PRESIDENT  2013/15
Belo Horizonte – MG / BRAZIL

More articles by this author

Transcatheter Aortic Valve Implantation: Step by Step

Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   

Implante transcateter de bioprótesis aórtica. Selección de pacientes

Jorge Belardi2014-04-22Director del Departamento de Cardiología ICBA

Implante Transapical de Bioprotesis Aórtica Autoexpandible en Paciente Compasivo con Estenosis Aórtica Severa contraindicado para otros abordajes

Cohen Fernando2014-04-22Servicio de Hemodinamia y Cardiología IntervencionistaHospital Italiano de Buenos Aires

Cierre de Orejuela Auricular Izquierda: Técnica y Resultados

Aníbal Damonte2014-04-22Departamento de Hemodinamia y Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...